EpiConcept
- TED_NO_ID
- TEDNOID-dbc61d4c12525151
- Pais
- 🇫🇷 Francia · Paris (75011)
- Contratos ganados
- 11
- Valor total del contrato
- 20 400 869 EUR
- Primer contrato
- 25/07/2018
- Ultimo contrato
- 08/12/2023
Top 5 · Compradores publicos
- European Centre for Disease Prevention and Control (ECDC) 🇸🇪 5 contratos ganados
- European Centre for Disease Prevention and Control 🇸🇪 4 contratos ganados
- CHRU de Tours 🇫🇷 1 contratos ganados
- CHU de Reims 🇫🇷 1 contratos ganados
EpiConcept ha sido adjudicatario de 11 contratos publicos indexados en Tendervue. Consulte a continuacion el detalle de las licitaciones, compradores publicos, categorias CPV/PSC e importes adjudicados a EpiConcept.
Active 2018-2023
4 buyers
11 contracts
Adjudicaciones (11)
| Fecha | Comprador | Descripcion | Importe | Procedimiento |
|---|---|---|---|---|
| 08/12/2023 | European Centre for Disease Prevention and Control (ECDC) | Improving Social Media Monitoring for Epidemic Intelligence – OJ/2023/PHF/26497 | 2 300 000 EUR | |
| 05/07/2023 | European Centre for Disease Prevention and Control (ECDC) | 3 500 000 EUR | ||
| 14/09/2022 | European Centre for Disease Prevention and Control (ECDC) | Establishing Severe Acute Respiratory Infections (SARI) Surveillance and Performing Hospital-based COVID-19 Transmission Studies | 2 299 984 EUR | |
| 14/09/2022 | European Centre for Disease Prevention and Control (ECDC) | Establishing Severe Acute Respiratory Infections (SARI) Surveillance and Performing Hospital-based COVID-19 Transmission Studies | 1 680 000 EUR | |
| 21/04/2022 | CHRU de Tours | Maintenance, hébergement et suivi d'exploitation du progiciel Néonat de la société Epiconcept, acquisition de licence(s) et de module(s) complémentaire(s), prestations associées | 1 EUR | |
| 10/02/2022 | CHU de Reims | Prestations de maintenance et d’assistance de la solution VOOZANOO, de la société EPICONCEPT, pour le CHU de Reims | 12 500 EUR | |
| 08/09/2021 | European Centre for Disease Prevention and Control (ECDC) | Enhanced laboratory support to perform assessment of vaccine effectiveness against SARS-CoV-2 infection | 1 928 400 EUR | |
| 05/02/2021 | European Centre for Disease Prevention and Control | Establishing Severe Acute Respiratory Infections (SARI) Surveillance and Performing Hospital-based Covid-19 Transmission Studies | 1 680 000 EUR | |
| 04/02/2021 | European Centre for Disease Prevention and Control | Establishing Severe Acute Respiratory Infections (SARI) Surveillance and Performing Hospital-based Covid-19 Transmission Studies | 2 299 984 EUR | |
| 25/04/2019 | European Centre for Disease Prevention and Control | 700 000 EUR | ||
| 25/07/2018 | European Centre for Disease Prevention and Control | Monitoring influenza vaccine effectiveness (seasonal and pandemic) in EU/EEA | 4 000 000 EUR |